SciELO - Scientific Electronic Library Online

 
vol.31 número6Cáncer de próstata órgano-confinado: Tratamiento con altas dosis de radioterapia (radioterapia de intensidad modulada)Ablación mediante radiofrecuencia intersticial (RITA) en el tratamiento del cáncer de próstata órgano-confinado índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Actas Urológicas Españolas

versión impresa ISSN 0210-4806

Resumen

ABASCAL JUNQUERA, J.M. et al. Brachyterapy in the localized prostate cancer. Actas Urol Esp [online]. 2007, vol.31, n.6, pp.617-626. ISSN 0210-4806.

Introduction and objectives: Considering the high frequency of localized prostate cancer in stages, at the moment there are minimally invasive techniques that compete with the classic surgery. One of them is the Low Dose Rate (LDR) Brachytherapy with permanent implants of I125 seeds. The objective of the present study is to expose our experience from the year 1998, when we made the first treatment, until today. The results and the morbidity of the patients over a 7 and a half years period are analyzed. Material and methods: A total of 800 patients were treated with LDR brachytherapy, with average age of 68 years and range between 48 and 83 years. In all patients the I125 seeds were used with Rapid-Strand and peripheral load by means of intraoperative planning. Results: The urinary rate of complications was of 3% of AUR, and 0.2% of urinary incontinence. The morbidity on the digestive apparatus was of a 12% intermittent bleeding, 2% of proctitis, and a 0.3% of rectal fistulas.

Palabras clave : Brachytherapy; Localized prostate cancer.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons